University of North Carolina at Greensboro

Ancora's Natalie Williams Named One of the "Top 50 Women Leaders in Education" by Executive Leadership Organization Women We Admire

Retrieved on: 
Thursday, October 12, 2023
Trident, Woman, Trident University International, MBA, Student, Ivy League, Ancora, University of North Carolina at Greensboro, University, Admire, Kansas, Marketing, Miller-Motte College, Management, Nursing, Education

DALLAS, Oct. 12, 2023 /PRNewswire/ -- Ancora Vice President of Client Operations Natalie Williams was recently named as one of the "Top 50 Women Leaders in Education" for 2023 by Women We Admire , a professional network of women business leaders in the United States and Canada.

Key Points: 
  • DALLAS, Oct. 12, 2023 /PRNewswire/ -- Ancora Vice President of Client Operations Natalie Williams was recently named as one of the "Top 50 Women Leaders in Education" for 2023 by Women We Admire , a professional network of women business leaders in the United States and Canada.
  • I am extremely proud of the meaningful work we are doing at Ancora to upskill and reskill America's workforce.
  • "It is a privilege and an honor to be recognized as one of the Top 50 Women Leaders in Education of 2023 by Women We Admire.
  • I am extremely proud of the meaningful work we are doing at Ancora to upskill and reskill America's workforce," said Williams.

Ryan Oglesby chosen as ENA President-Elect

Retrieved on: 
Monday, September 25, 2023
ENA, Emergency Nurses Association, Election Committee (Hong Kong), University, CFRN, Professional, Nursing, EMT, MBA, Mentorship, University of North Carolina at Charlotte, Doctor of Philosophy, BSN, CEN, Nomination, EDS, RN, Nursing care plan, ED, Piedmont, MHA, University of North Carolina at Greensboro, Management

SCHAUMBURG, Ill., Sept. 25, 2023 /PRNewswire/ -- Ryan Oglesby, PhD, MHA, RN, CEN, CFRN, NEA-BC, has been elected 2024 president-elect of the Emergency Nurses Association.

Key Points: 
  • ENA members also elect Secretary/Treasurer, Director and 3 Committee Members
    SCHAUMBURG, Ill., Sept. 25, 2023 /PRNewswire/ -- Ryan Oglesby, PhD, MHA, RN, CEN, CFRN, NEA-BC, has been elected 2024 president-elect of the Emergency Nurses Association.
  • Oglesby has served on the ENA Board of Directors since 2019 and is the current secretary/treasurer.
  • Oglesby has been involved with ENA for nearly 20 years, including serving terms as president of the Piedmont Chapter and the North Carolina ENA State Council.
  • In addition to choosing a president-elect, ENA members elected a new secretary/treasurer and two directors to the ENA Board of Directors.

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, August 8, 2023
Workforce, Amgen, Sutro Biopharma, Therapy, Drug development, University, Senior, VaxGen, Regeneron Pharmaceuticals, CD3, Neoplasm, CMC, Therapeutic index, PDT, Toxicity, Bristol Myers Squibb, Research, Medicine, CMO, University of North Carolina at Greensboro, EDT, Science, Trial of the century, Patent, Patient, AbbVie, Investment, EGFR, Ipilimumab, Colorectal cancer, SAN, CD71, Webcast, ADC, Jazz Pharmaceuticals, BMS, Interferon, Safety, IND, Tumor microenvironment, Biology, TCB, Management, Vaccine, Pharmaceutical industry, Cryptocurrency, Quality, Chemistry

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today reported second quarter 2023 financial results and provided a business update.

Key Points: 
  • - Management to hold conference call today at 5 p.m. EDT / 2 p.m. PDT -
    SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today reported second quarter 2023 financial results and provided a business update.
  • In the private placement, CytomX sold pre-funded warrants and accompanying tranche warrants at a combined price of $2.08 per share.
  • Yu-Waye (Wayne) Chu, M.D., joins CytomX as Chief Medical Officer – In July 2023, CytomX announced the appointment of Yu-Waye (Wayne) Chu, M.D., as Chief Medical Officer (CMO).
  • CytomX management will host a conference call and simultaneous webcast today at 5 p.m. EDT (2 p.m. PDT) to discuss the financial results and provide a business update.

Feeding Matters, Emory University and Children's Healthcare of Atlanta to Host Groundbreaking Consensus Summit on PFD and ARFID

Retrieved on: 
Thursday, July 27, 2023
Consensus, ARFID, Emory University, University of Virginia School of Nursing, Communication, University, Eating disorder, Pediatrics, Parent, Eating, Feeding disorder, Hope, Research, University of North Carolina at Greensboro, Doctor of Philosophy, Associate, Disorder, Child, Head, School, Children's Healthcare of Atlanta, Nursing, Diagnosis, PFD, Environment, Avoidant/restrictive food intake disorder

PHOENIX, July 27, 2023 /PRNewswire-PRWeb/ -- Feeding Matters, a leading nonprofit organization dedicated to advancing the understanding and treatment of pediatric feeding disorder, is proud to announce its affiliation with Emory University, a renowned academic institution at the forefront of medical research, and Children's Healthcare of Atlanta, the only freestanding pediatric health system in Georgia, for the upcoming Consensus Summit on Pediatric Feeding Disorder (PFD) and Avoidant/Restrictive Food Intake Disorder (ARFID).

Key Points: 
  • Dr. Estrem's expertise lies in pediatric healthcare research, with a specific focus on pediatric feeding difficulties.
  • Inspired by her own child, Dr. Estrem has pursued a career in feeding research, making her a valuable contributor to facilitate the summit.
  • Pediatric feeding disorder (PFD) and Avoidant/Restrictive Food Intake Disorder (ARFID) are complex conditions that significantly impact the lives of children and adults alike.
  • Feeding Matters' long-standing commitment to consensus building and collaboration has been instrumental in driving progress in the field of pediatric feeding disorder.

First Life Saved with AI-Discovered Repurposed Medicine for Castleman Disease with Significant Potential Applications to Treat Other Illnesses

Retrieved on: 
Thursday, July 13, 2023
Storm, Pennsylvania State University, University, Argyreia nervosa, Spectrum, Food, COVID-19, Adalimumab, Hope, Organ dysfunction, Research, University of North Carolina at Greensboro, Idiopathic multicentric Castleman disease, Sepsis, Dassault Group, Hospice, Crohn's disease, Duct (flow), Juvenile idiopathic arthritis, Publication, Castleman, Castleman disease, Patient, Castleman Disease Collaborative Network, Algorithm, Immune system, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, ALS, Family, Skin, Rheumatoid arthritis, Disease, Medical device, Pharmaceutical industry, Angiosarcoma, Medidata Solutions

PHILADELPHIA, July 13, 2023 /PRNewswire/ -- A patient's life was saved after researchers at the University of Pennsylvania, Castleman Disease Collaborative Network, Medidata, a Dassault Systèmes company, and Every Cure, led by Dr. David Fajgenbaum, utilized AI to uncover a previously unknown use for an existing drug, adalimumab, to treat idiopathic multicentric Castleman disease (iMCD). Every Cure and its partners are developing medical databases and AI algorithms to unlock new uses for existing medicines across all diseases, and the latest scoring identified adalimumab as the most promising treatment for iMCD out of all 3,000 approved drugs.

Key Points: 
  • Every Cure and its partners are expanding upon this discovery to harness a novel AI algorithm that calculates the potential use of every drug to treat every disease.
  • iMCD is a rare and life-threatening disorder that involves hyperactivation of the body's immune system which causes uncontrolled organ dysfunction.
  • The only FDA-approved treatment works in a portion of those diagnosed with iMCD, leaving the majority of patients with limited options.
  • The algorithm scores every existing drug's potential to treat every known disease based on worldwide knowledge from publications and databases.

National Humanities Center Names 2023-24 Teacher Advisory Council

Retrieved on: 
Thursday, June 29, 2023
International High School, National Humanities Center, Secondary school, Teaching, Prospect Heights, North Central Texas College, Humanities, School, Student, D'Evelyn Junior/Senior High School, University, NHC, University of North Carolina at Greensboro, Miami Palmetto Senior High School, Education, Hellertown, Pennsylvania, Tutoring, Nursing, Veterinary medicine, Hatmaking, Nightclub, St. Louis

DURHAM, N.C., June 29, 2023 /PRNewswire/ -- The National Humanities Center (NHC) has announced the selection of twenty talented educators from across the country as members of its 2023–24 Teacher Advisory Council. These teachers, from schools in twelve states, will work with the Center's staff in piloting, evaluating, and promoting NHC resources and professional development programs for collegiate and pre-collegiate educators.

Key Points: 
  • DURHAM, N.C., June 29, 2023 /PRNewswire/ -- The National Humanities Center (NHC) has announced the selection of twenty talented educators from across the country as members of its 2023–24 Teacher Advisory Council .
  • For 40 years the National Humanities Center has included teacher professional development as a key part of its mission.
  • The Teacher Advisory Council was formed by the National Humanities Center to aid in its ongoing effort to help teachers be more effective in humanities classrooms.
  • For forty years the National Humanities Center has included teacher professional development as a key part of its mission.

apree health Releases the 2023 Workforce Health Index

Retrieved on: 
Wednesday, May 10, 2023
Presenteeism, National Alliance, Obesity, Prevalence, Population health, Health, Diabetes, Absenteeism, Cancer, Quality of life, Castlight Health, Pharmacy, Wang, University of North Carolina at Greensboro, PCP, UNC Greensboro Spartans men's basketball, Risk, SAN, Growth, Society for Public Health Education, Annual report, Pharmaceutical industry, Health care, Health insurance

SAN FRANCISCO, May 10, 2023 /PRNewswire/ -- apree health, formerly Castlight Health and Vera Whole Health, today released the 2023 Workforce Health Index, providing key findings from analyses of medical and pharmaceutical spend data of its commercially-insured populations in the U.S. This year's annual report, which is based on an analysis of more than 220 million medical and pharmaceutical claims and 4.1 million unique people, offers insights into historical trends and forecasts of 2023 medical and prescription drug spend. In addition, the report highlights the critical role of employers in engaging employees in their care, and the impact employers and payers can have on addressing the affordability and access crisis within the U.S. healthcare system. Key trends identified in the 2023 Workforce Health Index include:

Key Points: 
  • Index reveals worrisome trends in preventive care utilization, escalating prescription drug spend, and the positive impact of primary care on population health
    SAN FRANCISCO, May 10, 2023 /PRNewswire/ -- apree health , formerly Castlight Health and Vera Whole Health, today released the 2023 Workforce Health Index , providing key findings from analyses of medical and pharmaceutical spend data of its commercially-insured populations in the U.S.
  • The 2023 Workforce Health Index is a valuable resource to help employers and payers prioritize strategies to mitigate these risks, improve health outcomes, and reduce unnecessary costs."
  • The 2023 Index reveals that engagement with primary care is associated with improved health risk and flattening of medical spend.
  • View the complete 2023 Workforce Health Index for more details on the report findings.

BioInnovation Institute & Science Prize for Innovation winners announced

Retrieved on: 
Thursday, April 13, 2023
Blood pressure, Memorial Sloan Kettering Cancer Center, Prize, Swiss Federal Institute of Technology, Honey, Chromosome, University, Tetraplegia, Neuroprosthetics, Breeding, Spinal cord, Cancer, Polymer, MSKCC, Innovation, Research, MIT, University of North Carolina at Greensboro, USD, Associate, Paralysis, Entrepreneurship, Seumas McNally Grand Prize, EPFL, BII, Swiss Federal Institute of Aquatic Science and Technology, SCI, Pharmaceutical industry, Science

The annual award hosted by BioInnovation Institute and Science aims to recognize and celebrate bold researchers who are asking fundamental questions at the intersection of life sciences and entrepreneurship.

Key Points: 
  • The annual award hosted by BioInnovation Institute and Science aims to recognize and celebrate bold researchers who are asking fundamental questions at the intersection of life sciences and entrepreneurship.
  • The three winners will have their essays published in the journal, Science, and will be invited into BII's entrepreneurial ecosystem.
  • In addition, the Grand Prize winner will receive USD 25,000 and each finalist will receive USD 10,000 at a grand award ceremony in Copenhagen, Denmark, April 27th.
  • The BII & Science Prize for Innovation is in its second year, with applications received from around the world.

BioInnovation Institute & Science Prize for Innovation winners announced

Retrieved on: 
Thursday, April 13, 2023
Blood pressure, Memorial Sloan Kettering Cancer Center, Prize, Swiss Federal Institute of Technology, Honey, Chromosome, University, Tetraplegia, Neuroprosthetics, Breeding, Spinal cord, Cancer, Polymer, MSKCC, Innovation, Research, MIT, University of North Carolina at Greensboro, USD, Associate, Paralysis, Entrepreneurship, Seumas McNally Grand Prize, EPFL, BII, Swiss Federal Institute of Aquatic Science and Technology, SCI, Pharmaceutical industry, Science

The annual award hosted by BioInnovation Institute and Science aims to recognize and celebrate bold researchers who are asking fundamental questions at the intersection of life sciences and entrepreneurship.

Key Points: 
  • The annual award hosted by BioInnovation Institute and Science aims to recognize and celebrate bold researchers who are asking fundamental questions at the intersection of life sciences and entrepreneurship.
  • The three winners will have their essays published in the journal, Science, and will be invited into BII's entrepreneurial ecosystem.
  • In addition, the Grand Prize winner will receive USD 25,000 and each finalist will receive USD 10,000 at a grand award ceremony in Copenhagen, Denmark, April 27th.
  • The BII & Science Prize for Innovation is in its second year, with applications received from around the world.

Global Real Estate Brokerage The Agency Launches First Office in Virginia Beach

Retrieved on: 
Tuesday, April 4, 2023
Diamond, Real, Intelligence, YMCA, Partnership, University, Marketing, The Wall Street Journal, Culture, Partner, University of North Carolina at Greensboro, American City Business Journals, Economics, Ministry of Finance and Economic Planning (Ghana), Financial Times, School, United States Department of the Army, The Real Housewives of Beverly Hills, National Association, Netflix, Inside Business, Inman, Real estate, Agency, Coastal Virginia Offshore Wind

LOS ANGELES, April 4, 2023 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its first franchise office in Virginia Beach, Virginia. The new locale, which will be known as The Agency Virginia Beach, is the firm's second office in the state of Virginia, joining the brokerage's growing network of 80 offices in the U.S., Canada, Mexico, the Caribbean, and Europe. The Virginia Beach office will be led by industry veterans Alan and Betsy Thompson who will serve as Managing Partners. The duo opened The Agency Chesapeake in December 2022.

Key Points: 
  • LOS ANGELES, April 4, 2023 /PRNewswire-PRWeb/ -- Global real estate brokerage The Agency proudly announces the launch of its first franchise office in Virginia Beach, Virginia.
  • The Virginia Beach office will be led by industry veterans Alan and Betsy Thompson who will serve as Managing Partners.
  • The Agency Virginia Beach is located at 408 Laskin Road, Suite B, Virginia Beach, VA 23322.
  • Watch The Agency on Buying Beverly Hills, a new real estate occu-soap highlighting the high-stakes world of luxury real estate in Los Angeles, currently streaming on Netflix.